Source: Annual Congress 2007 - Pulmonary infections and inflammation
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. W. Pletz, F. Bloos, O. Burkhardt, S. Heino, J. Martens-Lobenhoffer, S. Bode-Böger, T. Welte (Hannover, Jena, Wuppertal, Magdeburg, Germany). Steady state pharmacokinetics of moxifloxacin in critically ill patients. Eur Respir J 2007; 30: Suppl. 51, 478

Member's Comments

No comment yet.

Related content which might interest you: Clinical efficacy of moxifloxacin in severely ill patients with CAP Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Iloprost delivery and efficacy in critically ill patients Source: Annual Congress 2007 - Problems in intensive care medicine Year: 2007 Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with pulmonary infections Source: Eur Respir J 2006; 28: Suppl. 50, 275s Year: 2006 Steroid use in elderly critically ill COVID-19 patients Source: Eur Respir J, 58 (4) 2100979; 10.1183/13993003.00979-2021 Year: 2021 Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients Source: Eur Respir J, 53 (4) 1802107; 10.1183/13993003.02107-2018 Year: 2019 The practice of sedation in critically ill patients Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Clinically important drug interactions with anti-infective agents in critically ill patients with respiratory disorders Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Antibiotics in the critically ill and septic patient Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections Year: 2013 Population pharmacokinetics and pharmacodynamics analysis of vancomycin in patients with severe lower respiratory tract gram-positive infections Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Alterations in serum lipid profile in critically ill septic patients: a prospective study Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Which tracheostomy in critically ill patients? Source: Annual Congress 2008 - Tracheostomy in critically ill patients Year: 2008 Why tracheostomy in critically ill patients? Source: Annual Congress 2008 - Tracheostomy in critically ill patients Year: 2008 Pharmacokinetics of instilled versus nebulized tobramycin or Imipenem in mechanically ventilated ICU patients Source: Eur Respir J 2002; 20: Suppl. 38, 16s Year: 2002 Breath markers in critically ill patients Source: Annual Congress 2004 - New tools and new concepts in respiratory monitoring Year: 2004 Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients Source: Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016 Year: 2017 Pharmacokinetics and pharmacodynamics of ciclesonide and its active principle after inhalative and intravenous administration in healthy subjects Source: Eur Respir J 2002; 20: Suppl. 38, 110s Year: 2002 Indicators of systemic inflammation in critically ill patients with COVID-19. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Population pharmacokinetics and pharmacodynamics of meropenem in elderly Chinese with lower respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010